Recalls, Market Withdrawals, & Safety Alerts
The list below provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this page. See Additional information about recalls for a more complete listing.
The Recalls, Market Withdrawals & Safety Alerts are available on FDA’s website for three years before being archived. To search archived content, visit Search FDA Archive and input the name of the product and/or company name in the Search terms box as well as the year to get the most inclusive search results. To scroll through archived Recalls, Market Withdrawals & Safety Alerts content by year, see the Recall and Safety Alerts Archive.
* FDA Employees: Use Chrome to Subscribe until further notice.
Date | Brand Name(s) | Product Description | Product Type | Recall Reason Description | Company Name | Terminated Recall | Excerpt |
---|---|---|---|---|---|---|---|
Arrow | Arrow-Trerotola™ Over-The-Wire PTD® Kit Percutaneous Thrombolytic Device: 7FR | Medical Devices | Inner lumen may detach from the device’s basket | Teleflex Incorporated | … of native arterio-venous (AV) fistulae and synthetic dialysis grafts. The products involved in the recall are as … | ||
B. Braun | Ceftazidime for Injection USP (2g) and Dextrose for Injection USP (50 ml) in Duplex® Container | Drugs | Out-of-Specification Results for High Molecular Weight Polymers | Braun Medical Inc | Terminated | … key product areas include nutrition, pharmacy admixture and dialysis. The company is committed to eliminating … | |
Baxter | intravenous (IV) solutions: 0.9% Sodium Chloride Injection, USP, 250 mL VIAFLEX Plastic Container and 70% Dextrose Injection (2000 mL) USP | Drugs | Labeled as Eliquis5 mg was found to contain Eliquis 2.5 mg tablets | Baxter International Inc. | Terminated | … and may also be used as a priming solution in hemodialysis procedures. 70% Dextrose Injection (2000 mL) USP is … and hospital products, including home, acute and in-center dialysis; sterile IV solutions; infusion systems and … |